Prof Martine Piccart speaks to ecancer about the new tools that we can use in clinical practice to make better decisions for women with early breast cancer regarding their need for chemotherapy or not.
This is a talk that she is presenting at BGICC 2021. She initially explains this topic by saying that breast cancer has a propensity to spread in the body very quickly and once the cancer metastasises it is hard to treat the patient. This is why controlling early breast cancer is very important. She then talks about the most frequent breast cancer sub-types which is hormone receptor positive breast cancer. Prof Piccart then talks about endocrine therapy. She explains that patients who have a higher risk of relapse can be given chemotherapy and then explains the standard by which the risk of relapse can be measured.
In the end she talks about the benefits of this analysis that can prevent women from getting unnecessary chemotherapy and can also save money and the overall health of that patient.